1-3 of 3
Keywords: metabolic syndromes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Hepatic accumulation of S-adenosylmethionine in hamsters with non-alcoholic fatty liver disease associated with metabolic syndrome under selenium and vitamin E deficiency

Available to Purchase
Josep Maria del Bas, Benjamín Rodríguez, Francesc Puiggròs, Silvia Mariné, Miguel Angel Rodríguez, David Moriña, Lluís Armengol, Antoni Caimari, Lluís Arola
Journal: Clinical Science
Clin Sci (Lond) (2019) 133 (3): 409–423.
https://doi.org/10.1042/CS20171039
Published: 05 February 2019
...Josep Maria del Bas; Benjamín Rodríguez; Francesc Puiggròs; Silvia Mariné; Miguel Angel Rodríguez; David Moriña; Lluís Armengol; Antoni Caimari; Lluís Arola Progression of non-alcoholic fatty liver disease (NAFLD) in the context of metabolic syndrome (MetS) is only partially explored due...
View article titled, Hepatic accumulation of S-adenosylmethionine in hamsters with non-alcoholic fatty liver disease associated with metabolic syndrome under selenium and vitamin E deficiency
Open the PDF for Hepatic accumulation of S-adenosylmethionine in hamsters with non-alcoholic fatty liver disease associated with metabolic syndrome under selenium and vitamin E deficiency in another window
Includes: Supplementary data
Articles

Cross-talk between renal lithogenesis and atherosclerosis: an unveiled link between kidney stone formation and cardiovascular diseases

Available to Purchase
Asokan Devarajan
Journal: Clinical Science
Clin Sci (Lond) (2018) 132 (6): 615–626.
https://doi.org/10.1042/CS20171574
Published: 20 March 2018
... proteins promote the crystallization processes [ 17 , 18 ]. Atherosclerosis cardiovascular disease Dyslipidemia Kidney stone metabolic syndromes oxidative stress Kidney stones and CVDs are complex multifactorial results from interactions between environmental and genetic factors [ 1–3...
View article titled, Cross-talk between renal lithogenesis and atherosclerosis: an unveiled link between kidney stone formation and cardiovascular diseases
Open the PDF for Cross-talk between renal lithogenesis and atherosclerosis: an unveiled link between kidney stone formation and cardiovascular diseases in another window
Articles

Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR −/− mouse model of atherosclerosis

Open Access
Dawn Thompson, Nicola Morrice, Louise Grant, Samantha Le Sommer, Emma K. Lees, Nimesh Mody, Heather M. Wilson, Mirela Delibegovic
Journal: Clinical Science
Clin Sci (Lond) (2017) 131 (20): 2489–2501.
https://doi.org/10.1042/CS20171066
Published: 29 September 2017
... Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) . atherosclerosis metabolic syndromes protein tyrosine phosphatases Cardiovascular disease (CVD) is a general term used to describe all the conditions affecting...
View article titled, Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR −/− mouse model of atherosclerosis
Open the PDF for Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR −/− mouse model of atherosclerosis in another window
Includes: Supplementary data